{
    "code": "02023595",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023595",
    "time": "2016-11-18 20:23:06",
    "許可證字號": "衛署藥輸字第023595號",
    "註銷狀態": "已註銷",
    "註銷日期": "98\/08\/18",
    "註銷理由": "自請註銷",
    "有效日期": "98\/09\/10",
    "發證日期": "91\/11\/26",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202359502",
    "中文品名": "新邁寧口服溶液１００公絲／公撮",
    "英文品名": "CYCLOSPORINE ORAL SOLUTION 100MG\/ML",
    "適應症": "預防器官移植及骨髓移植後之移植排斥、預防移植反宿主疾病、活動性有失明危險之中部或後部非感染性葡萄膜炎，使用傳統療法無法控制者、BEHCET病一再發炎、且已侵犯視網膜者、替代性療法無效或不適用之嚴重乾癬、標準療法無效或不適用之嚴重類風濕性關節炎、以類固醇治療無效或對類固醇有依賴性的原發性腎病症候群(活體檢視【BIOPSY】主要為微小病變疾病或局部環節腎絲球硬化症)，經細胞穩定(CYTOSTATIC)治療無效且腎功能指數在正常值50%以上之病人。",
    "劑型": "180液劑",
    "包裝": "50公撮玻璃瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "CYCLOSPORIN"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "6201189984  罕而寶企業有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F070036000  MANUFACTURED BY BANNER PHARMACAPS (CANADA) LTD.",
        "製造廠廠址": "6005 47TH AVENUE, OLDS, ALBERTA, CANADA T4H 1S7",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049091001 抗排斥醫藥製劑Immunosuppressive preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F460258000  PLIVA, INC.",
            "製造廠廠址": "72 EAGLE ROCK AVENUE P.O. BOX 371 EAST HANOVER, NJ 07936 U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9250000700",
            "成分名稱": "CYCLOSPORIN",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ]
}